Just one last very powerful observation on Cavendish and it is quote from Michael Moffat.

Michael Moffat, Cavendish co-founder and chief executive officer explains, "… The quality and originality of Resverlogix Corp.'s research and scientific insights into epigenetic drug discovery positions them to make a major contribution to the treatment of cardiovascular and autoimmune diseases."

<!--[if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Cambria; mso-hansi-theme-font:minor-latin;} </style> <![endif]-->

This is a very powerful endorsement from a person who must have allot of confidence in RVX and it's science to be confident enough in RVX to recommend them to his large group of wealthy philanthropist investors.

Cheers

Toinv